Pharmaceutical Products Supply
Oryginalny tytuł ogłoszenia
Bulgaria – Pharmaceutical products – „Доставка на лекарствени продукти за нуждите на МБАЛ “Д-р Братан Шукеров”АД“
Ocena szansy
Skąd ta ocena?
Szansa
70 / 100
Złożoność
60 / 100
Czynniki ryzyka
Stringent licensing requirements may exclude non-Bulgarian entities without proper authorization.
Structured data indicates EU funding, but XML notice states no EU funds. This inconsistency could affect contract fundi...
Restricted procedure — pre-qualification required
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Przegląd
Moderate opportunityKluczowe fakty
- BGN 8.4M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Supply of pharmaceutical products as defined in the technical specification.
- Estimated quantities are provided but not guaranteed.
Pokaż pełne podsumowanie
This tender is a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products to MBAL Dr. Bratan Shukerov AD in Smolyan, Bulgaria. The estimated total value is 8,416,335 BGN for a 24-month period. The procedure is restricted, with award based on lowest price. The deadline for initial applications is 24 June 2027, far in the future, suggesting a long-term DPS. Key eligibility requires valid manufacturing or wholesale authorization for medicinal products in Bulgaria or EU equivalent. Note: There is an inconsistency regarding EU funding—structured data indicates EU-funded, but the XML notice states no EU funds.
Ryzyka
Stringent licensing requirements may exclude non-Bulgarian entities without proper authorization.
Structured data indicates EU funding, but XML notice states no EU funds. This inconsistency could affect contract fundi...
Restricted procedure — pre-qualification required
Analiza może być niepełna
Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.
Kluczowe wymagania
Technical
- Must hold valid manufacturing or wholesale authorization for medicinal products in Bulgaria or EU equivalent.
- Compliance with Bulgarian Medicines Act (ZLPHM).
- Candidates must apply for inclusion in the DPS; initial application required.
Wymagania mogą być niepełne.
Kryteria udzielenia
Lot 1
Zamawiający
Lokalizacja
гр. Смолян, BGR
Strona
Profil zamawiającego
Identyfikator
120503871
Działalność
Health
Części (1)
LOT-0001
Pharmaceutical Products Supply
Supply of medicinal products as per the technical specification (not analyzed). Quantities are estimated and not guaranteed. The DPS runs for 24 months from September 2024.
BGN 8.4M
Szacowana wartość
Lokalizacja
Czas trwania
Kategoria
Kryteria udzielenia
Szczegóły kryteriów
Обществената поръчка ще се възложи въз основа на икономически най-изгодната оферта при критерий за възлагане „най-ниска цена”
Uwaga do wartości
Pokaż oryginalne dane TED
Oryginalny tytuł części
„Доставка на лекарствени продукти за нуждите на МБАЛ “Д-р Братан Шукеров”АД“
Oryginalny opis TED
„Доставка на лекарствени продукти за нуждите на МБАЛ “Д-р Братан Шукеров”АД“. Лекарствените продукти са посочени по номенклатурни единици и са подробно представени по лекарствени форми, количество лекарствено вещество, единица мярка и необходимо прогнозно количество в приложената към документацията първоначална „Техническа спецификация“. Посочените количества в приложената към документацията „Техническа спецификация“ са прогнозни и не задължават Възложителя да ги закупи в пълен обем, а съобразно своята необходимост.
Szczegóły zamówienia
- Data publikacji
- 26 Jun 2024
- Języki
- Bulgarian
Metadane referencyjne
- Podstawa prawna
- 32014L0024
Identyfikatory referencyjne
- ID przetargu
- 377194-2024
Dokumenty (1)
Podobne przetargi
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Ocena szansy
Skąd ta ocena?
Szansa
70 / 100
Złożoność
60 / 100
Czynniki ryzyka
Stringent licensing requirements may exclude non-Bulgarian entities without proper authorization.
Structured data indicates EU funding, but XML notice states no EU funds. This inconsistency could affect contract fundi...
Restricted procedure — pre-qualification required
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications